Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loteprednol Etabonate for Dry Eye
NCT00560638Phase 2Completed
- Sponsor
- Bausch + Lomb
- Start
- Nov 2005
- Primary completion
- Feb 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of loteprednol etabonate ophthalmic gel 0.38% in dry eye syndrome (DED), sponsored by Bausch + Lomb. Started Nov 2005; status: completed.
02
Drugs
loteprednol etabonate ophthalmic gel 0.38%
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00560638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00560638.